Health policy support under extreme uncertainty: the case of cervical cancer in Cambodia

Bente, 2009, Disease modeling for Ebola and Marburg viruses, Dis Models Mech, 2, 12, 10.1242/dmm.000471

Beutels, 2008, Funding of drugs: do vaccines warrant a different approach?, Lancet Infect Dis, 8, 727, 10.1016/S1473-3099(08)70258-5

Briggs AH, Claxton K, Sculpher MJ (2006) Decision modelling for health economic evaluation. Oxford university press, Oxford

Briggs, 2012, Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6, Value Health, 15, 835, 10.1016/j.jval.2012.04.014

Bruce, 2000, Indoor air pollution in developing countries: a major environmental and public health challenge, Bull World Health Organ, 78, 1078

Burger, 2014, Prevention of HPV-related cancers in Norway: cost-effectiveness of expanding the HPV vaccination program to include pre-adolescent boys, PLoS One, 9, e89974, 10.1371/journal.pone.0089974

Caro, 2012, Modeling good research practices—overview a report of the ISPOR-SMDM modeling good research practices task force-1, Med Decis Making, 32, 667, 10.1177/0272989X12454577

Couture, 2012, Cervical human papillomavirus infection among young women engaged in sex work in Phnom Penh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection, BMC Infect Dis, 12, 166, 10.1186/1471-2334-12-166

Edejer, 2003

Flessa, 2011, Basing care reforms on evidence: the Kenya health sector costing model, BMC health Serv Res, 11, 128, 10.1186/1472-6963-11-128

Frederick, 2002, Time discounting and time preference: a critical review, J Econ Lit, 40, 351, 10.1257/jel.40.2.351

Gillison ML (2004) Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Seminars in oncology, vol 31. Elsevier, pp 744–754

Goldhaber-Fiebert, 2006, Estimating the cost of cervical cancer screening in five developing countries, Cost Eff Resour Alloc, 4, 13, 10.1186/1478-7547-4-13

Goldie, 2001, Policy analysis of cervical cancer screening strategies in low-resource settings, JAMA J Am Med Assoc, 285, 3107, 10.1001/jama.285.24.3107

Goldie, 2005, Cost-effectiveness of cervical-cancer screening in five developing countries, N Engl J Med, 353, 2158, 10.1056/NEJMsa044278

Goldie, 2008, Health and economic outcomes of HPV 16, 18 vaccination in 72 GAVI-eligible countries, Vaccine, 26, 4080, 10.1016/j.vaccine.2008.04.053

Gray, 2001, Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda, Lancet, 357, 1149, 10.1016/S0140-6736(00)04331-2

Heidenberger, 1993, A system dynamics model for AIDS policy support in Tanzania, Eur J Oper Res, 70, 167, 10.1016/0377-2217(93)90036-M

Hey, 2010, The descriptive and predictive adequacy of theories of decision making under uncertainty/ambiguity, J Risk Uncertain, 41, 81, 10.1007/s11166-010-9102-0

Huchko, 2014, A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya, Bull World Health Organ, 92, 195, 10.2471/BLT.13.122051

Husereau, 2013, Consolidated health economic evaluation reporting standards (CHEERS) statement, BMC Med, 11, 80, 10.1186/1741-7015-11-80

ICO (2014) HPV information centre—data query. http://www.hpvcentre.net/dataquery.php. Accessed 31 Jan 2014

Jerven M (2013) Poor numbers: how we are misled by African development statistics and what to do about it. Cornell University Press, Oxford

Jit, 2011, Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models, BMC Med, 9, 54, 10.1186/1741-7015-9-54

Kahn, 2009, HPV vaccination for the prevention of cervical intraepithelial neoplasia, N Engl J Med, 361, 271, 10.1056/NEJMct0806938

Karnon, 2011, Calibrating models in economic evaluation, Pharmacoeconomics, 29, 51, 10.2165/11584610-000000000-00000

Kim, 2008, Modeling cervical cancer prevention in developed countries, Vaccine, 26, K76, 10.1016/j.vaccine.2008.06.009

Lane PA (1984) The state of the Tanzanian economy. In: E. R. B. Paper. 1984: Dar-es-Salaam

Legood, 2005, Screening for cervical cancer in India: how much will it cost? A trial based analysis of the cost per case detected, Int J Cancer, 117, 981, 10.1002/ijc.21220

Lowy, 2006, Prophylactic human papillomavirus vaccines, J Clin Investig, 116, 1167, 10.1172/JCI28607

Mandelblatt, 2002, Costs and benefits of different strategies to screen for cervical cancer in less-developed countries, J Natl Cancer Inst, 94, 1469, 10.1093/jnci/94.19.1469

Mandelblatt JS et al (2002) Benefits and costs of using HPV testing to screen for cervical cancer. JAMA J Am Med Assoc 287(18):2372–2381

Marra, 2009, Effectiveness and cost effectiveness of human papillomavirus vaccine, Pharmacoeconomics, 27, 127, 10.2165/00019053-200927020-00004

Martin, 2012

Meyer M (1996) Operations research—systemforschung. Fischer, Jena, Stuttgart

Palanuwong, 2007, Alternative cervical cancer prevention in low-resource settings: experiences of visual inspection by acetic acid with single-visit approach in the first five provinces of Thailand, Aust N Z J Obstet Gynaecol, 47, 54, 10.1111/j.1479-828X.2006.00680.x

Peace, 2008

Philips, 2006, Good practice guidelines for decision-analytic modelling in health technology assessment, Pharmacoeconomics, 24, 355, 10.2165/00019053-200624040-00006

Phongsavan, 2012, Detection of human papillomavirus among women in Laos: feasibility of using filter paper card and prevalence of high-risk types, Int J Gynecol Cancer, 22, 1398, 10.1097/IGC.0b013e3182664b6b

Pitman, 2012, Dynamic transmission modeling: a report of the ISPOR-SMDM modeling good research practices task force-5, Value Health, 15, 828, 10.1016/j.jval.2012.06.011

Pourrut, 2005, The natural history of Ebola virus in Africa, Microbes Infect, 7, 1005, 10.1016/j.micinf.2005.04.006

Ramachandran, 2010, Diabetes in Asia, Lancet, 375, 408, 10.1016/S0140-6736(09)60937-5

Rooney C (1992) Antenatal care and maternal health: how effective is it? A review of the evidence. Antenatal care and maternal health: How effective is it? A review of the evidence. World Health Organization, Geneva

Roth M, Heidenberger K (1998) Strategic investment in HIV/AIDS control programmes: a system-dynamics-based economic evaluation. In: Operations research proceedings 1997. Springer, pp 575–580

Royal Government of Cambodia (2010) Cambodian Demographic and Health Survey 2010. Royal Governement of Cambodia, Phnom Penh

2012

2014

Sankaranarayanan, 2009, HPV screening for cervical cancer in rural India, N Engl J Med, 360, 1385, 10.1056/NEJMoa0808516

Sauerborn, 1996, Age bias, but no gender bias, in the intra-household resource allocation for health care in rural Burkina Faso, Health Transit Rev, 6, 131

Schiffman, 2005, The promise of global cervical-cancer prevention, N Engl J Med, 353, 2101, 10.1056/NEJMp058171

Schiffman, 2007, Human papillomavirus and cervical cancer, Lancet, 370, 890, 10.1016/S0140-6736(07)61416-0

Schmitt, 2004, The big five related to risky sexual behaviour across 10 world regions: differential personality associations of sexual promiscuity and relationship infidelity, Eur J Pers, 18, 301, 10.1002/per.520

Seinfeld J (2013) Cost-benefit analysis of cancer care and control: the case of cervical, colorectal and breast cancer in low and middle incomes countries. http://isites.harvard.edu/fs/docs/icb.topic1011506.files/CCC%20-%20Breast_Cervical%20and%20Colorectal%20cancer%20cases_AB.pdf. Accessed 15 Apr 2014

Sharif B et al (2012) Uncertainty analysis in population-based disease microsimulation models. Epidemiol Res Int 2012:610405. doi:10.1155/2012/610405

Sharma, 2012, Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand, BJOG Int J Obstet Gynaecol, 119, 166, 10.1111/j.1471-0528.2011.02974.x

Sterman J (2000) Business dynamics. Irwin-McGraw-Hill, Boston

Tan-Torres ET, World Health Organization (2003) Making choices in health: WHO guide to cost-effectiveness analysis. World Health Organization, Geneva

Tilson W et al (2006) Guide to analyzing the cost-effectiveness of community public health prevention approaches, Office of the Assistant Secretary for Planning and Evaluation, U.S., Department of Health and Human Services, Washington, DC

University of health science and Ministry of Health (2010) Prevalence of non-communicable disease risk factors in Cambodia. STEPS Survey Country Report 2010. Royal Government of Cambodia, Phnom Penh

Vijayaraghavan, 2009, Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa, Gynecol Oncol, 112, 377, 10.1016/j.ygyno.2008.08.030

von der Schulenburg J-MG et al (2007) Deutsche Empfehlungen zur gesundheitsökonomischen Evaluation. Präsidium ab 1. Januar 2008, p 23

Walker, 2003, Defining uncertainty: a conceptual basis for uncertainty management in model-based decision support, Integrat Assess, 4, 5, 10.1076/iaij.4.1.5.16466

Walt, 2001

Walt, 1994, Reforming the health sector in developing countries: the central role of policy analysis, Health Policy Plan, 9, 353, 10.1093/heapol/9.4.353

Wawer, 2005, Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda, J Infect Dis, 191, 1403, 10.1086/429411

WHO (2006) Comprehensive cervical cancer control: a guide to essential practice. World Health Organization, Geneva

WHO (2011) Scaling up action against noncommunicable diseases: how much will it cost? World Health Organisation, Geneva

WHO (2013) Comprehensive cervical cancer prevention and control: a healthier future for girls and women. World Health Organization, Geneva

WHO (2014a) GLOBOCAN. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed 23 Jan 2014

WHO (2014b) Health statistics and health information systems 2014. http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html. Accessed 2 Jan 2014

World Bank (2014) GDP per capita (current US$). http://data.worldbank.org/indicator/NY.GDP.PCAP.CD. Accessed 23 Jan 2014

World Economic Forum (2014) A charter for health data. http://www.weforum.org/issues/charter-health-data. Accessed 6 Oct 2014

World Health Organization (2002) National cancer control programmes: policies and managerial guidelines. World Health Organization, Geneva

2006

Wurthwein, 2001, Measuring the local burden of disease. A study of years of life lost in sub-Saharan Africa, Int J Epidemiol, 30, 501, 10.1093/ije/30.3.501

Yang, 2004, Cervical cancer as a priority for prevention in different world regions: an evaluation using years of life lost, Int J Cancer, 109, 418, 10.1002/ijc.11719